South African doctor who first spotted the Covid omicron variant says symptoms seem ‘mild’ so far...
Omicron Variant Drives Rise in Covid-19 Hospitalizations in South Africa Hot Spot...
Moderna CEO says it will take months to clear a new Covid vaccine targeting omicron...
BioNTech starts work on Omicron-specific vaccine...
Pfizer could have a new vaccine against omicron Covid variant in less than 100 days, CEO Bourla says...
WHO: Omicron poses ‘very high’ global risk and is likely to spread
UnitedHealth Group taps Wilson as new chief medical officer...
Verdict expected in TeamHealth lawsuit against UnitedHealthcare: 4 things to know...
MARWOOD: “White bagging” is increasingly being utilized by insurers to control provider-administered drug spend...
Anesthesiologists accuse Blues plan of abusing surprise billing ban...
Humana reaches value-based care deal with Minnesota-based Allina Health...
In competitive market for MSK, Sword valued at $2B...
Outside investors pay up for Medicare brokers...
CVS, Walgreens, Walmart found liable in their first trial over U.S. opioid epidemic...
Walgreens bets all its chips on a new healthcare strategy. Will patients buy in?
Bain, Hellman & Friedman Near Deal to Buy Athenahealth...
MedArrive nabs $25M to ramp up at-home health services, expand into new states...
Here are the policies and reforms that could reshape healthcare in the $2T bill just passed by the House...
Bain Capital nabs majority stake in InnovaCare...
CVS Taps Pharmacy Leader To ‘Enhance’ Health Hub Store Formats...
Amazon's healthcare business has landed Hilton as a key customer...
Amwell narrows 2021 revenue outlook due to delta variant impact on telehealth visit volume...
Health insurers look to flip the script on consumer experience...
Oscar Health posts another loss in Q3 even as revenue soars...
Blue Cross NC teams with Teladoc for expanded telehealth services...
BI: Teladoc acquired Livongo to recreate healthcare. A rushed union, a wave of senior exits, and sky-high expectations are testing the $14 billion bet...
Anthem will acquire NY-based long-term care plan Integra Managed Care...
Express Scripts launches option for employers to cover over-the-counter COVID-19 tests...
Survey: These are the risk-based payment models health systems are pursuing...
Doximity's Q2 revenue soars 76% as company pegs valuation at nearly $14B...
Humana to offer Virta Health's diabetes care platform for self-funded employer plans...
DOJ investigating Oak Street Health...
Tumbles on U.S. Inquiry, Quarterly Loss...
You Might Like
CORONAVIRUS
REPORT: Pfizer expects to produce 80 million courses of COVID-19 antiviral pill...
U.K. Set to Deploy Merck’s Covid Pill in 10,000-Person Study...
Massachusetts calls on hospitals to reduce elective procedures amid staffing shortages...
Some Hospitals Prepare to Lose Staff Over Covid-19 Vaccination Mandate...
Germany considers a full Covid lockdown and mandatory vaccines...
Covid-19 Antibody Tests in Demand as People Worry About Immunity...
Canada gives full approval to J&J's single shot COVID-19 vaccine...
Gottlieb says breakthrough Covid infections more common than people realize due to weak monitoring...
EU says decision on J&J COVID-19 vaccine booster dose 'within weeks'...
Pfizer's COVID-19 vaccine trial data shows long-term efficacy in adolescents...
COVID rapid tests face holiday demand spike...
Britain to extend COVID booster rollout to over-40s...
8 lingering questions about the new Covid pills from Merck and Pfizer...
Pfizer Shot Generated Most Antibodies in Comparative Study...
GSK-Vir COVID-19 antibody muscle injection as effective as intravenous shot...
FDA recalls 2.2 million Ellume COVID-19 home tests due to false positives...
NIH 'not done' fighting Moderna over Covid vaccine patents, director Francis Collins says...
Nearly 1 million kids 5–11 on track for first week COVID vaccine...
Moderna says Covid vaccine has fewer breakthrough cases than Pfizer’s, but higher myocarditis rates in young men...
Pfizer-BioNTech seek FDA authorization for COVID boosters for all adults...
U.S. to buy $1 billion more worth of Merck's COVID pill...
FOLLOW HEALTHCARE REPORT ON TWITTER...
JOIN HEALTHCARE REPORT'S DAILY EMAIL LIST HERE...
Patient possibly cured of Type 1 diabetes after participating in an early-stage clinical trial of a stem cell treatment by Vertex Pharmaceuticals...
Pear’s digital therapeutic for alcohol use disorder gets breakthrough designation...
Vaccibody gets a new name and loads up with nearly $1B in biobucks for new vaccine pact with Regeneron...
GlaxoSmithKline places a risky bet on Arrowhead's RNA drug in the failure-strewn NASH field...
Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drug...
Elizabeth Holmes admits she added drugmakers’ logos to Theranos reports...
Government rests its case in criminal trial of Theranos founder Elizabeth Holmes...
FDA clears first VR-based tool for for lower-back pain...
Biotech Alnylam Rises on Possible Interest from Novartis, Dicerna Deal...
J&J Pharma Executive Reveals Playbook for Standalone Drugmaker...
Biden signs into law infrastructure bill that pauses controversial rebate rule...
Cardinal Health to Test Drone Delivery to Pharmacies...
BD's $2B annual M&A war chest, connected care devices at heart of growth plan...
Part B premiums set to rise in 2022 as Medicare braces for potential high-cost therapies like Aduhelm...
Biden picks former FDA Commissioner Dr. Robert Califf to run the agency...
BioNTech sets sights on cancer...
Telehealth unicorn Thirty Madison goes brick-and-mortar with in-person hair restoration clinic...
Hims & Hers launches mobile app for subscription members on Q3 revenue surge...
AstraZeneca Plans to Start Selling Covid-19 Vaccines at Profit...
U.S. judge temporarily halts Johnson & Johnson talc cases, moves them to New Jersey...
The Core Legal Strategy Against Opioid Companies May Be Faltering...
Theranos lab deficiencies posed ‘immediate jeopardy’ to patients, 2016 government audit warned...
J&J plans to split into two companies...
Emergent slumps as U.S. terminates COVID-19 vaccine manufacturing deal...
REUTERS: Drugmakers pushed aggressive diabetes therapy. Patients paid the price...
Novartis cuts uneasy 20-year ties to Roche with $20.7 billion voting stake sale...
You Might Like
